FMP

FMP

Owlet, Inc. (NYSE:OWLT) Faces Capital Efficiency Challenges

-

twitterlinkedinfacebook
blog post cover photo

Image credit: Google Images

Owlet, Inc. (NYSE:OWLT) is a company that focuses on developing smart baby monitoring products. These products are designed to provide parents with real-time data on their infants' health and well-being. Despite its innovative offerings, Owlet faces challenges in capital efficiency, as highlighted by its financial metrics.

Owlet's Return on Invested Capital (ROIC) is -60.66%, which is significantly lower than its Weighted Average Cost of Capital (WACC) of 12.28%. This negative ROIC indicates that Owlet is not generating sufficient returns to cover its cost of capital, suggesting inefficiencies in capital utilization. This is a concerning sign for investors as it implies that the company is not currently using its capital effectively.

In comparison, ATI Physical Therapy, Inc. (ATIP) stands out among the peers with a ROIC of 0.36% and a WACC of 5.83%. This positive ROIC, albeit small, is higher than its WACC, indicating that ATI is generating returns above its cost of capital. This makes ATI the most efficient in terms of capital utilization among the companies analyzed.

Sharecare, Inc. (SHCR) and Science 37 Holdings, Inc. (SNCE) both have negative ROICs, with -13.79% and -101.22% respectively. Their ROICs are less than their WACCs, indicating inefficiencies in capital utilization. Science 37 Holdings, in particular, shows a severe inefficiency with a ROIC to WACC ratio of -14.48, highlighting significant challenges in capital management.

Other Blogs

Aug 22, 2025 7:00 AM - Danny Green

MannKind Corporation's Capital Efficiency in the Biopharmaceutical Industry

MannKind Corporation (NASDAQ:MNKD) is a biopharmaceutical company that focuses on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes. The company's flagship product, Afrezza, is an inhalable insulin used to control blood sugar levels in ...

blog post title

Aug 22, 2025 9:21 AM - davit kirakosyan

Stifel Lifts McDonald’s Price Target To $315, Keeps Hold Rating

Stifel raised its price target on McDonald’s Corp. (NYSE:MCD) to $315 from $300 while maintaining a Hold rating, following reports the fast-food giant has reached a deal with franchisees to lower prices on certain combo meals. According to the Wall Street Journal, the agreement will reduce prices...

blog post title